- Catalog
The Research Essentials, Without the Guesswork.
A focused collection today, with more peptides coming soon. Every batch is tested by HPLC and mass spectrometry at independent U.S. laboratories, with potency, purity, and endotoxin results documented in its COA.
- Metabolic Research
- In stock
A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic regulation and body composition in clinical research.
- In stock
A 39-residue synthetic linear peptide that acts as a dual agonist at both the GIP and GLP-1 receptors. A C20 fatty diacid chain at Lys-20 drives albumin binding for a once-weekly circulation profile.
- In stock
A long-acting GLP-1 receptor agonist: a 31-residue analog of human GLP-1 (~94% sequence homology) carrying a C18 fatty diacid chain via a linker that drives reversible albumin binding for extended circulation.
- In stock
A naturally occurring copper tripeptide that promotes tissue remodeling, wound healing, and collagen synthesis in animal and in vitro studies.
- Out of stock
A quad-peptide combination of BPC-157, TB-500, GHK-Cu, and KPV targeting complementary angiogenic, cellular migration, extracellular matrix remodeling, and anti-inflammatory pathways in preclinical research.
- Out of stock
A 13-amino acid linear peptide analog of alpha-melanocyte-stimulating hormone that selectively activates MC1R to stimulate eumelanin synthesis and photoprotective pathways in clinical research.